Amgen Close to Buying Onyx Pharmaceuticals for $125/Share -NY TImes

The New York Times is reporting that Amgen (NASDAQ: AMGN ) is close to a deal to acquire Onyx Pharmaceuticals (NASDAQ: ONXX ) for $125 per share. The deal could be announced on Monday, according to sources. Onyx rejected an offer of $120 per share from Amgen. Onyx Pharmaceuticals